Feature
MOTS-c: Where the Evidence Ends
Studies offer clues about ageing and metabolism. What do they actually tell us about human health—and where does expert opinion take over?
Startupticker.ch
Juturna Bio receives CHF 50,000 grant for brain-aging research
FIF granted Juturna Bio CHF 50,000 to support epigenetic reprogramming proof‑of‑concept in ageing brain cells.
Key takeaways
- Juturna Bio is developing epigenetic approaches for ageing brain cells.
- The grant supports early research, not a proven clinical treatment.
- Alzheimer's disease was named as the project's initial target.
